Evidence map›Paper›PMID 39172179›Full record

ArticleEuropean journal of nuclear medicine and molecular imaging2024

[

Yang Liu, Peipei Tang, Simin Peng, Jinmei Zhong, Zexin Xu, Jiawei Zhong, Jin Su, Yuhua Zhong, Kongzhen Hu

Abstract read
PubMed Publisher
In one paragraph

Article in European journal of nuclear medicine and molecular imaging, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Collagen Hybridizing Peptide-Based Radiotracers for Molecular Imaging of Collagen Turnover in Pulmonary Fibrosis.Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Yang Liu *Department of Nuclear Medicine, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Peipei Tang *Department of Rehabilitation Medicine, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Simin PengDepartment of Nuclear Medicine, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Jinmei ZhongDepartment of Nuclear Medicine, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Zexin XuDepartment of Nuclear Medicine, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Jiawei ZhongDepartment of Nuclear Medicine, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Jin SuState Key Laboratory of Respiratory Diseases, National Clinical Research Center for Respiratory Diseases, Guangzhou Institute of Respiratory Health, First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China. sujin@gird.cn.
Yuhua ZhongDepartment of Rehabilitation Medicine, Nanfang Hospital, Southern Medical University, Guangzhou, China. zhongbinyue@163.com.
Kongzhen HuDepartment of Nuclear Medicine, Nanfang Hospital, Southern Medical University, Guangzhou, China. stonglass@163.com.ORCID 0000-0002-7889-9576

Funding

Basic and Applied Basic Research Foundation of Guangdong Province 2022A1515012642National Natural Science Foundation of China 82272032National Natural Science Foundation of China 82272585
6 · The paper itself

Abstract

purposePulmonary fibrosis is an irreversible scar-forming condition for which there is a lack of non-invasive and specific methods for monitoring its progression and therapy efficacy. However, the disease is known to be accompanied by collagen accumulation. Here, we developed a novel positron emission tomography (PET) probe targeting type I collagen to evaluate its utility for the non-invasive assessment of pulmonary fibrosis.

methodsWe designed a

results[

conclusion[

Indexed as

Collagen Type IPulmonary FibrosisAnimalsDisease Models, AnimalFluorine RadioisotopesLungMaleMicePositron-Emission TomographyPositron Emission Tomography Computed TomographyRadiopharmaceuticalsCollagen Type IFluorine-18Fluorine RadioisotopesRadiopharmaceuticals[18F]AlF-CBPPET imagingPulmonary fibrosisType I collagen

Identifiers

PMID39172179

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.